Clinical Research
News & Careers
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile


Bristol-Myers Squibb Company 

38 Jackson Road

Devens  Massachusetts  01434  U.S.A.
Phone: n/a Fax: n/a


Bristol-Myers Squibb is a global biopharmaceutical company dedicated to helping patients prevail against serious disease.

We have delivered nine new products to patients in the last seven years for the treatment of psychiatric disorders, cancer, HIV, chronic hepatitis B and rheumatoid arthritis. We anticipate up to 6 additional regulatory approvals or submissions through 2012. In addition, scores of investigational medicines are advancing through our pharmaceutical development pipeline for such additional diseases as diabetes and cardiovascular disease, solid organ transplant rejection, Alzheimer's and obesity.

Bristol-Myers Squibb is recognized as having one of the most productive pipelines in the industry. Two of our marketed productive pipelines in the industry. Two of our marketed medicines and a number of investigational products are biologics. In the fight against serious disease, biologics - or protein-derived therapies - are playing an increasingly prominent role.

In our quest to help patients prevail, we are redefining our company and transforming ourselves for the future. By uniquely combining the strengths of a traditional pharmaceutical company with the attributes of a successful biotech company, we are becoming a new kind of enterprise, a next generation BioPharma. We are focused - agile and flexible, and infused with the entrepreneurial culture of an innovative biotech. Yet, at the same time, we are large enough to marshal the resources necessary to invest in our pipeline and bring new medicines to patients in need.

As a BioPharma leader, we are complementing and enhancing our internal capabilities with innovative alliances, partnerships and acquisitions. We call this our String of Pearls strategy.

Over the years, Bristol-Myers Squibb and its employees have received numerous distinguished awards and recognitions, including the National Medal of Technology and the Lasker Award for Medical Research. Recently, Bristol-Myers Squibb was included among Barron's 2009 Most Respected Companies Survey. Also, we've been hailed year after year as one of the best companies for working mothers and executive women, and as an acknowledged industry leader in environment, health, and safety management.

 Key Statistics

Ownership: Public

Web Site: Bristol-Myers Squibb Company
Symbol: BMY

 Company News
Bristol-Myers Squibb Company (BMY) Reports Second Quarter 2014 Financial Results 7/24/2014 10:06:57 AM
Bristol-Myers Squibb Company (BMY) Appoints Jitendra Tyagi As India Country Head 7/24/2014 6:53:27 AM
Bristol-Myers Squibb Company (BMY) To Announce Results For Second Quarter On July 24 7/1/2014 12:03:10 PM
A 4-Week Hepatitis C Cure? Bristol-Myers Squibb Company (BMY) To Test Drugs With Gilead Sciences, Inc. (GILD)'s Sovaldi 6/20/2014 6:52:42 AM
Cardax Pharmaceuticals Inc. Snags Former Novartis AG (NVS), Bristol-Myers Squibb Company (BMY), And Boehringer Ingelheim Corporation Executives As Directors 6/17/2014 6:24:46 AM
Bristol-Myers Squibb Company (BMY) Release: Giovanni Caforio, M.D., Appointed Chief Operating Officer And Elected To Board Of Directors 6/9/2014 11:19:05 AM
Bristol-Myers Squibb Company (BMY): Big Pharma's Small Wonder 6/4/2014 8:11:22 AM
South San Francisco's CytomX Therapeutics, Inc. Inks Potential $348 Million Cancer-Fighting Deal With Bristol-Myers Squibb Company (BMY) 5/27/2014 6:25:35 AM
Bristol-Myers Squibb Company (BMY) To Hold Investor Teleconference To Discuss American Society of Clinical Oncology Highlights 5/16/2014 6:52:51 AM
Bristol-Myers Squibb Company (BMY) To Present At UBS Global Healthcare Conference 5/12/2014 10:02:28 AM